KetamineOne Capital (MEDI) Intends to Apply for a Proposed US IPO

Go back to KetamineOne Capital (MEDI) Intends to Apply for a Proposed US IPO

Ketamine One Announces Intention to Submit Draft Registration Statement for Proposed U.S. Initial Public Offering

November 9, 2021 3:00 AM EST

Director Steven Inglefield Has Also Been Appointed Chief Operating Officer of the Company

VANCOUVER, British Columbia, Nov. 09, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (Ketamine One or the Company) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that it intends to confidentially submit a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission... More